Association between certain non–small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death‐ligand 1 inhibition

This study aimed to analyze the association between driver mutations and predictive markers for some anti–tumor agents in non–small cell lung cancer (NSCLC). A cohort of 785 Chinese patients with NSCLC who underwent resection from March 2016 to November 2017 in the First Affiliated Hospital of Guang...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wenhua, Guo, Minzhang, Pan, Zhenkui, Cai, Xiuyu, Li, Caichen, Zhao, Yi, Liang, Hengrui, Yang, Haiying, Wang, Zhen, Chen, Wenting, Xu, Chuhong, Yang, Xinyun, Sun, Jianyu, He, Ping, Gu, Xia, Yin, Weiqiang, He, Jianxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549909/
https://www.ncbi.nlm.nih.gov/pubmed/31033100
http://dx.doi.org/10.1111/cas.14032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549909/
https://www.ncbi.nlm.nih.gov/pubmed/31033100
http://dx.doi.org/10.1111/cas.14032

Ejemplares similares